GGrantIndex
Sort

40,608 grants matching prostate cancer

???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???

$303,926
Peter Anthony Crooks · Univ Of Arkansas For Med Scis · R01 · FY2014 · CA

Prostate cancer chemoprevention by penta-galloyl-glucose

$303,925
Junxuan Lu · Texas Tech University Health Scis Center · R01 · FY2012 · CA

Biochemical and Cell-Based HTS Assays for RGS17 Inhibitors

$303,925
David L Roman · University Of Iowa · R01 · FY2014 · CA

Multi-parametric MRI Determination of Prostate Cancer Aggressiveness and Extent

$303,925
Gregory John Metzger · University Of Minnesota · R01 · FY2012 · CA

Multi-parametric MRI Determination of Prostate Cancer Aggressiveness and Extent

$303,925
Gregory John Metzger · University Of Minnesota · R01 · FY2011 · CA

Low Level Traces Mapping using Monochromatic X-Rays

$303,908
X-Ray Optical Systems, Inc. · R44 · FY2002 · RR

Oligonucleotide Synthesis & NanoConstructs Core

$303,908
Teri Wang Odom · Northwestern University At Chicago · U54 · FY2016 · CA

Mechanism of Gene Repression in the Kidney

$303,865
Sanjeevkumar R Patel · University Of Michigan At Ann Arbor · R01 · FY2010 · DK

CHARACTERIZING THE PROSTATE CANCER-SUPPRESSIVE ROLE OF NCOA6 AND TARGETING ITS DEFICIENCY-ACTIVATED PATHWAY FOR TREATING PROSTATE CANCER

$303,827
Baylor College Of Medicine · · FY2019 · Defense Health Agency

Development of small molecule inhibitors of protein kinase D

$303,826
Qiming Jane Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · CA

New Target Antigens for Prostate Cancer Immunotherapy

$303,809
Vaccinex, Inc. · R43 · FY2004 · CA

PROSTATE CANCER METASTATIC COLONIZATION--ROLE OF MKK4

$303,807
University Of Chicago · R01 · FY2001 · CA

GLUCOCORTICOIDS &VITAMIN D: ROLE IN ANTI-TUMOR EFFECTS

$303,771
University Of Pittsburgh At Pittsburgh · R01 · FY2000 · CA

Validation of a New Target for Prostate Cancer Therapy

$303,763
Sidney Kimmel Cancer Center · R01 · FY2004 · CA

Genetically Engineered Viruses for Prostate Cancer Therapy

$303,755
Robert L Martuza · Massachusetts General Hospital · R01 · FY2014 · CA

MYC RNAI-PT COMBINATION NANOTHERAPY FOR METASTATIC PROSTATE CANCER TREATMENT

$303,750
The Johns Hopkins University · · FY2015 · Department of the Army

TIMP-1 REGULATORY FACTORS IN HUMAN PROSTATE CANCER

$303,745
Mcp Hahnemann University · R01 · FY2000 · CA

Eastern Cooperative Oncology Group

$303,739
Johns Hopkins University · U10 · FY2005 · CA

HEDGEHOG SIGNALING IN RESPONSE TO TISSUE INJURY AND IN NEOPLASIA

$303,730
Philip A Beachy · Johns Hopkins University · P01 · FY2009 · CA

Regulation of Alternative Splicing of FGFR2 pre-mRNA

$303,721
Mariano A. Garcia-Blanco · Duke University · R01 · FY2007 · GM

Regulation of Alternative Splicing of FGFR2 pre-mRNA

$303,721
Mariano A. Garcia-Blanco · Duke University · R01 · FY2008 · GM

PLANT ANTITUMOR AGENTS

$303,719
Kuo-Hsiung Lee · Univ Of North Carolina Chapel Hill · R01 · FY2008 · CA

PROSTATIC VASCULOGENIC MIMICRY: A NEW METASTATIC PATHWAY

$303,678
University Of Iowa · R01 · FY2001 · CA

PROSTATE CANCER METASTATIC COLONIZATION--ROLE OF MKK4

$303,643
University Of Chicago · R01 · FY2002 · CA

Biology of Tumor-Stroma Interaction

$303,635
Leland W. Chung · Cedars-Sinai Medical Center · P01 · FY2009 · CA